Association between various dosage forms of semaglutide and ocular adverse events in a real-world setting
The results of this study identified a significant difference between subcutaneous and oral semaglutide in ocular ADE risk, providing some evidence for dosage form selection and risk monitoring for clinical use.
Authors
- Lao M (ORCID: https://orcid.org/0000-0001-6101-9125)
- Yongmei Huang (ORCID: https://orcid.org/0000-0001-6248-2832)
- Guosong Wu (ORCID: https://orcid.org/0000-0002-7365-8087)
- Yiyun Feng (ORCID: https://orcid.org/0009-0001-9373-2643)
- Liting Zheng
- Tao Zhao (ORCID: https://orcid.org/0000-0002-6209-7480)
Institutions
- Southern Medical University (CN)
Publication Details
- Journal
- BMC Ophthalmology
- Published
- 2025-04-27
- DOI
- https://doi.org/10.1186/s12886-025-04096-7
- Citations
- 9
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 11.65